Disclosure detail

Basilea Pharmaceutica AG, Allschwil

01.10.2026 · T1QA1000B5

In brief

On 01.10.2026, a person holding the function "Executive member of the board of directors / senior management" at Basilea Pharmaceutica AG, Allschwil disclosed a sale worth CHF 61’034 to SIX Exchange Regulation.

By amount, this ranks #7 of 27 management sales disclosed at Basilea Pharmaceutica AG, Allschwil over the previous 12 months.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

A executive member of the board of directors / senior management of Basilea Pharmaceutica AG, Allschwil declared a "Sale" transaction on 01.10.2026.

SIX publishes the manager's function, never their name: no individual is named in management transactions.

Transaction date01.10.2026

Issuing companyBasilea Pharmaceutica AG, Allschwil

ISINCH0011432447

Transaction sideSale

Management functionExecutive member of the board of directors / senior management

Security typeRegistered shares

Quantity900

Unit priceCHF 67.82

AmountCHF 61’034

ConditionsExersale/net settlement of employee stock options: Exercise of 17'813 employee stock options with a strike price of CHF 67.50 and of 2'187 employee stock options with a strike price of CHF 45.80, through net settlement. The exercise resulted in the issuance of 900 shares, representing the net value of the options after deduction of the exercise price. The shares were immediately sold on the market.

ExchangeXSWX

Notification IDT1QA1000B5

Other Basilea Pharmaceutica AG, Allschwil insider transactions

These figures aggregate public disclosures. They are not investment advice.